Biological outcome measurements for behavioral interventions in multiple sclerosis
Open Access
- 11 May 2011
- journal article
- Published by SAGE Publications in Therapeutic Advances in Neurological Disorders
- Vol. 4 (4), 217-229
- https://doi.org/10.1177/1756285611405252
Abstract
Behavioral interventions including exercise, stress management, patient education, psychotherapy and multidisciplinary neurorehabilitation in general are receiving increasing recognition in multiple sclerosis (MS) clinical practice and research. Most scientific evaluations of these approaches have focused on psychosocial outcome measures such as quality of life, fatigue or depression. However, it is becoming increasingly clear that neuropsychiatric symptoms of MS are at least partially mediated by biological processes such as inflammation, neuroendocrine dysfunction or regional brain damage. Thus, successful treatment of these symptoms with behavioral approaches could potentially also affect the underlying biology. Rigidly designed scientific studies are needed to explore the potential of such interventions to affect MS pathology and biological pathways linked to psychological and neuropsychiatric symptoms of MS. Such studies need to carefully select outcome measures on the behavioral level that are likely to be influenced by the specific intervention strategy and should include biomarkers with evidence for an association with the outcome parameter in question. In this overview, we illustrate how biological and psychological outcome parameters can be combined to evaluate behavioral interventions. We focus on two areas of interest as potential targets for behavioral interventions: depression and fatigue.Keywords
This publication has 128 references indexed in Scilit:
- Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patientsAnnals of Neurology, 2010
- Salivary cortisol in depressed patients versus control persons: A systematic review and meta-analysisPsychoneuroendocrinology, 2010
- Smaller Cornu Ammonis 2–3/Dentate Gyrus Volumes and Elevated Cortisol in Multiple Sclerosis Patients with Depressive SymptomsBiological Psychiatry, 2010
- The prednisolone suppression test in depression: Dose–response and changes with antidepressant treatmentPsychoneuroendocrinology, 2010
- Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAELaboratory Investigation, 2010
- Does hypothalamic–pituitary–adrenal axis hypofunction in chronic fatigue syndrome reflect a ‘crash’ in the stress system?Medical Hypotheses, 2009
- Aerobic fitness is associated with gray matter volume and white matter integrity in multiple sclerosisBrain Research, 2009
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major DepressionBiological Psychiatry, 2009
- The molecular neurobiology of depressionNature, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008